लोड हो रहा है…
हमारे कवर किए 84 कंपनियाँ, जिनमें से 78 ग्रेडेड
यहाँ हर कंपनी वृद्धि और नकदी बनाने की उन्हीं पाँच जाँचों से गुज़री है। यह उद्योग का वह वर्णन है जैसा वह आज बताता है — यह नहीं कि इनमें से क्या खरीदा जाए।
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | A | $45.7B | $39.19 | 65.32 | $17.3B | 4.1% |
| HLN | Haleon plc | B+ | $41.4B | $9.26 | 18.87 | $14.6B | 15.1% |
| TAK | Takeda Pharmaceutical Company Limited | B | $30.3B | $18.86 | 44.01 | $28.7B | -3.4% |
| ZTS | Zoetis Inc. | A+ | $29.4B | $71.05 | 11.71 | $9.5B | 27.5% |
| VTRS | VIATRIS INC. | C | $20.5B | $17.83 | — | $14.7B | -23.9% |
| UTHR | United Therapeutics Corporation | B+ | $20.4B | $475.45 | 17.02 | $3.2B | 41.6% |
| NBIX | NEUROCRINE BIOSCIENCES INC | A+ | $14.1B | $138.40 | 20.29 | $3.4B | 20.9% |
| ELAN | Elanco Animal Health Incorporated | A | $11.1B | $22.31 | — | $5B | -4.0% |
| RDY | DR. REDDY’S LABORATORIES LIMITED | B+ | $10.2B | $12.25 | 17.35 | $3.5B | 12.8% |
| ALKS | Alkermes plc. | B | $6.9B | $40.85 | 107.50 | $1.7B | 4.0% |
| HIMS | HIMS & HERS HEALTH, INC. | A- | $6.8B | $29.42 | — | $2.6B | -5.5% |
| LNTH | Lantheus Holdings, Inc. | A+ | $6.5B | $99.74 | 24.15 | $1.6B | 17.7% |
| AMRX | AMNEAL PHARMACEUTICALS, INC. | C | $6.3B | $19.77 | 40.35 | $3.1B | 5.0% |
| KNSA | Kiniksa Pharmaceuticals International, plc | A | $6.2B | $75.08 | 82.51 | $754M | 9.7% |
| LQDA | LIQUIDIA CORPORATION | A+ | $6.1B | $68.43 | 49.23 | $450.9M | 30.7% |
| INDV | Indivior Pharmaceuticals, Inc. | D | $4.2B | $35.82 | 12.84 | $1.3B | 26.7% |
| AMLX | Amylyx Pharmaceuticals, Inc. | D | $3.3B | $29.49 | — | $0.00 | — |
| RGC | Regencell Bioscience Holdings Limited | ग्रेड नहीं | $3.1B | $6.17 | — | — | — |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | C- | $2.5B | $42.66 | — | $830.4M | -13.2% |
| HCM | HutchMED (China) LIMITED | D | $2.4B | $13.94 | 26.81 | $549.1M | 3.3% |
| TRLV | TRULIEVE CANNABIS CORP. | D | $2.4B | $12.21 | — | $1.1B | -41.8% |
| PBH | PRESTIGE CONSUMER HEALTHCARE INC. | C+ | $2.2B | $46.61 | 13.06 | $1.1B | 15.6% |
| BCRX | BIOCRYST PHARMACEUTICALS, INC. | A | $2.2B | $8.59 | — | $940.6M | -40.9% |
| PRGO | Perrigo Company plc | F- | $2.1B | $15.42 | — | $4.1B | -41.9% |
| BHC | Bausch Health Companies Inc. | A | $2.1B | $5.69 | — | $10.9B | -10.1% |
| ALVO | ALVOTECH | B | $1.8B | $5.75 | 57.50 | $586.3M | 4.8% |
| XERS | XERIS BIOPHARMA HOLDINGS, INC. | F- | $1.7B | $9.10 | — | $335.4M | -5.1% |
| ETON | Eton Pharmaceuticals, Inc. | A+ | $1.6B | $57.68 | — | $105.6M | 12.0% |
| ANIP | ANI PHARMACEUTICALS, INC | A+ | $1.6B | $74.00 | 15.98 | $978.4M | 11.1% |
| PAHC | Phibro Animal Health Corporation | B | $1.4B | $34.45 | 14.12 | $1.5B | 6.6% |
| HROW | Harrow, Inc. | B- | $1.2B | $33.07 | — | $275.6M | -13.5% |
| CRON | CRONOS GROUP INC. | A | $1.2B | $3.34 | 16.70 | $179.1M | 39.1% |
| AMPH | Amphastar Pharmaceuticals, Inc. | A+ | $1.1B | $26.13 | 15.46 | $730M | 10.8% |
| PCRX | PACIRA BIOSCIENCES, INC. | A | $1B | $25.12 | 71.77 | $746.2M | 2.0% |
| COLL | Collegium Pharmaceutical, Inc. | A+ | $733.5M | $22.53 | 18.17 | $808.2M | 5.9% |
| IRWD | IRONWOOD PHARMACEUTICALS, INC. | C+ | $682.4M | $4.13 | 5.36 | $389.3M | 33.4% |
| AQST | Aquestive Therapeutics, Inc. | C | $587.4M | $4.68 | — | $54.1M | -144.6% |
| TLRY | Tilray Brands, Inc. | C- | $562.5M | $4.13 | — | $915.5M | -13.3% |
| GLAS | Glass House Brands Inc. | D- | $557.2M | $6.80 | — | $152.9M | -33.7% |
| EOLS | EVOLUS, INC. | B | $526.4M | $7.97 | — | $316.5M | -10.8% |
| KMDA | KAMADA LTD | C | $503M | $8.72 | 22.95 | $191.8M | 11.6% |
| TKNO | ALPHA TEKNOVA, INC. | B- | $500.9M | $9.33 | — | $43.7M | -38.4% |
| CGC | Canopy Growth Corp | D- | $398.3M | $0.94 | — | $207.3M | -79.2% |
| EBS | EMERGENT BIOSOLUTIONS INC. | C | $348.1M | $6.79 | — | $770.2M | -23.0% |
| BIOA | BIOAGE LABS, INC. | D- | $323.6M | $7.05 | — | $10.4M | -912.3% |
| INCR | INTERCURE LTD. | C- | $284.9M | $5.21 | — | $88.2M | -13.2% |
| EVO | Evotec SE | D- | $277.3M | $1.56 | — | $897M | -13.1% |
| ANIK | Anika Therapeutics, Inc. | B- | $272.6M | $20.37 | — | $120.7M | -3.1% |
| AKBA | AKEBIA THERAPEUTICS, INC. | C | $248.3M | $0.90 | — | $219.1M | -13.5% |
| SIGA | Siga Technologies INC | F- | $247.9M | $3.45 | — | $53.7M | -5.2% |
| ACB | AURORA CANNABIS INC | D | $230.6M | $4.10 | 145.20 | $226.3M | -42.4% |
| ORGO | ORGANOGENESIS HOLDINGS INC. | B- | $181.4M | $1.41 | — | $457.5M | -18.4% |
| CRDL | Cardiol Therapeutics Inc. | ग्रेड नहीं | $171.4M | $1.71 | — | — | — |
| DERM | Journey Medical Corp | C- | $168.2M | $6.14 | — | $68.2M | -9.0% |
| ADCT | ADC Therapeutics SA | D | $162.1M | $1.27 | — | $79.6M | -121.8% |
| LFCR | LIFECORE BIOMEDICAL, INC. | D | $159M | $4.20 | — | $128.9M | -30.0% |
| CPIX | Cumberland Pharmaceuticals Inc. | F- | $114M | $7.61 | — | $39.9M | -27.4% |
| OGI | ORGANIGRAM HOLDINGS INC. | C- | $104.8M | $1.10 | — | $183M | -9.6% |
| CTOR | Citius Oncology, Inc. | ग्रेड नहीं | $97.6M | $1.05 | — | — | — |
| ZYBT | Zhengye Biotechnology Holding Limited | D | $61.8M | $1.31 | 35.03 | $17.3M | -60.0% |
| SCYX | SCYNEXIS, Inc. | F- | $43.7M | $4.39 | 15.14 | $19.2M | -53.3% |
| IMCC | IM Cannabis Corp. | C | $36.4M | $2.84 | — | $32.3M | -39.1% |
| RMTI | ROCKWELL MEDICAL, INC. | B- | $33.7M | $8.37 | — | $69.4M | -7.3% |
| CPHI | CHINA PHARMA HOLDINGS, INC. | C- | $32.3M | $0.75 | — | $3.9M | -114.3% |
| BGM | BGM Group Ltd | F- | $27.2M | $0.24 | — | $37.9M | -52.6% |
| AYTU | AYTU BIOPHARMA, INC | C | $24.8M | $2.28 | — | $57.6M | -24.8% |
| TXMD | TherapeuticsMD, Inc. | F- | $23.7M | $2.05 | — | $3.3M | -6.6% |
| RDHL | REDHILL BIOPHARMA LTD. | F- | $22.5M | $0.50 | — | $286K | -150.0% |
| BFRI | Biofrontera Inc. | B- | $17.5M | $1.18 | — | $46.2M | -13.8% |
| TLPH | TALPHERA, INC. | C- | $16.8M | $1.18 | — | $1K | -15,07,600.0% |
| CABR | CARING BRANDS, INC. | F- | $12.8M | $1.24 | — | $4.2K | -1,83,255.2% |
| APUS | APIMEDS PHARMACEUTICALS US, INC. | ग्रेड नहीं | $10.9M | $7.25 | — | — | — |
| INM | INMED PHARMACEUTICALS INC. | D- | $7.6M | $1.38 | — | $4.5M | -278.7% |
| SNOA | SONOMA PHARMACEUTICALS, INC. | B- | $6.1M | $1.27 | — | $21.9M | -10.3% |
| GELS | Gelteq Limited | D- | $5.2M | $0.55 | — | $116.3K | -4,011.9% |
| SBFM | Sunshine Biopharma Inc. | C- | $3.3M | $0.84 | — | $35.3M | -16.5% |
| SHPH | SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | ग्रेड नहीं | $3M | $4.01 | — | — | — |
| UPC | Universe Pharmaceuticals INC | D- | $2.7M | $4.75 | — | $17.9B | -20.6% |
| SXTC | China SXT Pharmaceuticals, Inc. | F- | $2.5M | $2.57 | — | $1.1M | -545.2% |
| YCBD | cbdMD, Inc. | D- | $1.9M | $0.47 | — | $20.9M | -13.8% |
| IXHL | Incannex Healthcare Inc. | F- | $1.7M | $3.32 | — | $0.00 | — |
| PRFX | PRF Technologies Ltd. | B- | $811.3K | $0.98 | — | $17K | -29,541.2% |
| AKAN | AKANDA CORP. | F | $210.3K | $3.05 | 0.24 | $258.1K | -17,690.2% |
| OPTH | Optimi Health Corp. | ग्रेड नहीं | — | $4.82 | — | — | — |
मूल आँकड़े SEC रिपोर्टों से, भाव अंतिम बाज़ार-डेटा पास से। किसी भी स्तंभ से क्रम दें; जिन कंपनियों का आँकड़ा नहीं है वे दोनों दिशाओं में अंत में जाती हैं।
बाज़ार मूल्य के अनुसार क्रमित, सबसे बड़ी पहले; फिर से क्रम देने के लिए किसी भी स्तंभ पर क्लिक करें। जिन कंपनियों का आँकड़ा नहीं है वे दोनों दिशाओं में अंत में जाती हैं, क्योंकि P/E का न होना सस्ता होना नहीं, घाटे में होना बताता है। यहाँ कुछ भी सिफ़ारिश नहीं है।